Related references
Note: Only part of the references are listed.Vascular histone deacetylation by pharmacological HDAC inhibition
Haloom Rafehi et al.
GENOME RESEARCH (2014)
The primary microRNA-208b interacts with Polycomb-group protein, Ezh2, to regulate gene expression in the heart
Prabhu Mathiyalagan et al.
NUCLEIC ACIDS RESEARCH (2014)
The UCSC genome browser and associated tools
Robert M. Kuhn et al.
BRIEFINGS IN BIOINFORMATICS (2013)
Transcriptional Regulation Patterns Revealed by High Resolution Chromatin Immunoprecipitation during Cardiac Hypertrophy
Danish Sayed et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy
Roberto Papait et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Genes Are Often Sheltered from the Global Histone Hyperacetylation Induced by HDAC Inhibitors
John Halsall et al.
PLOS ONE (2012)
Cardiomyocyte NF-kappa B p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure
Tariq Hamid et al.
CARDIOVASCULAR RESEARCH (2011)
Multiple Facets of NF-κB in the Heart To Be or Not to NF-κB
Joseph W. Gordon et al.
CIRCULATION RESEARCH (2011)
Cardiac genes show contextual SWI/SNF interactions with distinguishable gene activities
Lisa Chang et al.
EPIGENETICS (2011)
Next generation histone deacetylase inhibitors: the answer to the search for optimized epigenetic therapies?
Florian Thaler et al.
EXPERT OPINION ON DRUG DISCOVERY (2011)
Isoform-selective HDAC inhibitors: Closing in on translational medicine for the heart
Timothy A. McKinsey
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Targeting Inflammation in Heart Failure with Histone Deacetylase Inhibitors
Timothy A. McKinsey
MOLECULAR MEDICINE (2011)
ENCODE whole-genome data in the UCSC genome browser (2011 update)
Brian J. Raney et al.
NUCLEIC ACIDS RESEARCH (2011)
Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy
Dian J. Cao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Targeted deletion of NF-kappa B p50 diminishes the cardioprotection of histone deacetylase inhibition
L. X. Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
BEDTools: a flexible suite of utilities for comparing genomic features
Aaron R. Quinlan et al.
BIOINFORMATICS (2010)
Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats
Abishek Iyer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
The clinical development of histone deacetylase inhibitors as targeted anticancer drugs
Paul A. Marks
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Biomarkers of inflammation in heart failure
Biykem Bozkurt et al.
HEART FAILURE REVIEWS (2010)
HDAC Inhibition Attenuates Inflammatory, Hypertrophic, and Hypertensive Responses in Spontaneously Hypertensive Rats
Jeffrey P. Cardinale et al.
HYPERTENSION (2010)
Chromatin regulation by Brg1 underlies heart muscle development and disease
Calvin T. Hang et al.
NATURE (2010)
Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
Bianca C. Bernardo et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
NF-kappa B activation is required for adaptive cardiac hypertrophy
Laura Zelarayan et al.
CARDIOVASCULAR RESEARCH (2009)
ChIP-seq: advantages and challenges of a maturing technology
Peter J. Park
NATURE REVIEWS GENETICS (2009)
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
Chunaram Choudhary et al.
SCIENCE (2009)
Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure
Pasquale Gallo et al.
CARDIOVASCULAR RESEARCH (2008)
Prevention of cardiac hypertrophy and heart failure by silencing of NF-κB
Sudhiranjan Gupta et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Combinatorial patterns of histone acetylations and methylations in the human genome
Zhibin Wang et al.
NATURE GENETICS (2008)
The impact of next-generation sequencing technology on genetics
Elaine R. Mardis
TRENDS IN GENETICS (2008)
Model-based Analysis of ChIP-Seq (MACS)
Yong Zhang et al.
GENOME BIOLOGY (2008)
Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of associated genes
Alvaro Rada-Iglesias et al.
GENOME RESEARCH (2007)
Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3β activity
Chinmay M. Trivedi et al.
NATURE MEDICINE (2007)
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome
Nathaniel D. Heintzman et al.
NATURE GENETICS (2007)
Cross-talk between histone modifications in response to histone deacetylase inhibitors - MLL4 links histone H3 acetylation and histone H3K4 methylation
Karl P. Nightingale et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy
Yongli Kong et al.
CIRCULATION (2006)
Regulation of antisense RNA expression during cardiac MHC gene switching in response to pressure overload
F Haddad et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Histone modifications: signalling receptors and potential elements of a heritable epigenetic code
KP Nightingale et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2006)
Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding
HJ Kee et al.
CIRCULATION (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Genome-wide map of nucleosorne acetylation and methylation in yeast
DK Pokholok et al.
CELL (2005)
Intrinsic histone-DNA interactions and low nucleosome density are important for preferential accessibility of promoter regions in yeast
EA Sekinger et al.
MOLECULAR CELL (2005)
Cardiac histone acetylation - therapeutic opportunities abound
TA McKinsey et al.
TRENDS IN GENETICS (2004)
Evidence for nucleosome depletion at active regulatory regions genome-wide
CK Lee et al.
NATURE GENETICS (2004)
Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction
XJ Du et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome
GN Liang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors
CL Antos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Histone and chromatin cross-talk
W Fischle et al.
CURRENT OPINION IN CELL BIOLOGY (2003)
Signaling chromatin to make muscle
TA McKinsey et al.
CURRENT OPINION IN CELL BIOLOGY (2002)
Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy
CL Zhang et al.
CELL (2002)
The human genome browser at UCSC
WJ Kent et al.
GENOME RESEARCH (2002)
Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure
B Bozkurt et al.
CIRCULATION (2001)
Share Paper
